A new trading day began on Monday, with Outlook Therapeutics Inc (NASDAQ: OTLK) stock price down -3.38% from the previous day of trading, before settling in for the closing price of $1.48. OTLK’s price has ranged from $0.87 to $12.85 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -25.00%. Meanwhile, its annual earnings per share averaged -2.19%. With a float of $15.23 million, this company’s outstanding shares have now reached $23.41 million.
Let’s determine the extent of company efficiency that accounts for 24 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Outlook Therapeutics Inc (OTLK) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Outlook Therapeutics Inc is 35.60%, while institutional ownership is 35.70%. The most recent insider transaction that took place on Sep 26 ’24, was worth 28,446. In this transaction Chief Financial Officer of this company bought 5,000 shares at a rate of $5.69, taking the stock ownership to the 5,946 shares. Before that another transaction happened on Mar 28 ’24, when Company’s Director bought 1,882 for $11.82, making the entire transaction worth $22,242. This insider now owns 5,049 shares in total.
Outlook Therapeutics Inc (OTLK) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -2.19% per share during the next fiscal year.
Outlook Therapeutics Inc (NASDAQ: OTLK) Trading Performance Indicators
Here are Outlook Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -10.75, a number that is poised to hit -0.80 in the next quarter and is forecasted to reach -2.37 in one year’s time.
Technical Analysis of Outlook Therapeutics Inc (OTLK)
Looking closely at Outlook Therapeutics Inc (NASDAQ: OTLK), its last 5-days average volume was 0.76 million, which is a jump from its year-to-date volume of 0.69 million. As of the previous 9 days, the stock’s Stochastic %D was 7.20%. Additionally, its Average True Range was 0.37.
During the past 100 days, Outlook Therapeutics Inc’s (OTLK) raw stochastic average was set at 7.15%, which indicates a significant decrease from 13.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 441.03% in the past 14 days, which was higher than the 181.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.5266, while its 200-day Moving Average is $6.8671. However, in the short run, Outlook Therapeutics Inc’s stock first resistance to watch stands at $1.4825. Second resistance stands at $1.5349. The third major resistance level sits at $1.5712. If the price goes on to break the first support level at $1.3938, it is likely to go to the next support level at $1.3575. Now, if the price goes above the second support level, the third support stands at $1.3051.
Outlook Therapeutics Inc (NASDAQ: OTLK) Key Stats
With a market capitalization of 32.51 million, the company has a total of 23,656K Shares Outstanding. Currently, annual sales are 0 K while annual income is -58,980 K. The company’s previous quarter sales were 0 K while its latest quarter income was 44,410 K.
